Hydroxychloroquine Sulfate Tablet, Film Coated
Product Images NDC 55154-2074

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxychloroquine Sulfate (NDC 55154-2074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4d47da53 Ac21 4acc B39b 413e3f26c7f7 01

FDA Label Image

A9ae8704 Fde0 4609 9155 23c3cd4554f7 00

A9ae8704 Fde0 4609 9155 23c3cd4554f7 00
This is a description of Hydroxychloroquine Sulfate Tablets, USP 200 mg. It is a prescription medication that is used to treat certain types of malaria and autoimmune diseases. The package contains 10 tablets and must be stored between 20-25°C. The medication is not child-resistant, so it must be kept out of reach of children. If dispensed for outpatient use, a child-resistant container should be utilized. The package contains the NDC number 68382.098, and it is manufactured by Zydus Pharmaceuticals (USA) Inc. and distributed by American Health Packaging, an AmerisourceBergen Company.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.